Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells

Diabetes

Volumn 51, Issue 6, 2002, Pages 1737-1744

  Shojima, Nobuhiro ^a,d   Sakoda, Hideyuki ^b,d   Ogihara, Takehide ^a,d   Fujishiro, Midori ^a,d   Katagiri, Hideki ^c,d   Anai, Motonobu ^b,d   Onishi, Yukiko ^b,d   Ono, Hiraku ^b,d   Inukai, Kouichi ^d   Abe, Miho ^a,d   Fukushima, Yasushi ^a,d   Kikuchi, Masatoshi ^b,d   Oka, Yoshitomo ^c,d   Asano, Tomoichiro ^a,d  

^a UNIVERSITY OF TOKYO   (Japan)

^b INSTITUTE FOR ADULT DISEASES   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

^d SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DEXAMETHASONE; GLUCOSE; GROWTH HORMONE; HORMONE; HUMAN GROWTH HORMONE; INSULIN; RESISTIN; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLUCOSE METABOLISM; HORMONAL REGULATION; INSULIN SENSITIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WHITE ADIPOSE TISSUE;

EID: 0036267020     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.6.1737     Document Type: Article

References (47)

1. The hormone resistin links obesity to diabetes
2. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation
3. Diabetes: Causes of insulin resistance
4. Signaling mechanisms that regulate glucose transport
5. Signaling pathways in insulin action: Molecular targets of insulin resistance
6. Turning down insulin signaling
7. Hyperinsulinemia does not compensate for peripheral insulin resistance in obesity
8. Role of insulin resistance in human disease
9. Obesity and insulin resistance
10. 14-3-3 Protein binds to insulin receptor substrate-1, one of the binding sites of which is in the phosphotyrosine binding domain
11. Leptin: The tale of an obesity gene
12. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
13. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade
14. Systemic and regional free fatty acid metabolism in type 2 diabetes
15. Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes
16. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys
17. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone
18. Metabolic effects of troglitazone on fat-induced insulin resistance in the rat
19. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ)
20. Regulation of PPARγ gene expression by nutrition and obesity in rodents
21. Thiazolidinediones in the treatment of insulin resistance and type II diabetes
22. PPAR gamma: Adipogenic regulator and thiazolidinedione receptor
23. Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists
24. Unraveling the mechanism of action of thiazolidinediones
25. Effect of dexamethasone on insulin binding, glucose transport, and glucose oxidation of isolated rat adipocytes
26. The effects of acute and chronic dexamethasone administration on insulin binding to isolated rat hepatocytes and adipocytes
27. Alterations in insulin binding induced by changes in vivo in the levels of glucocorticoids and growth hormone
28. Insulin and dexamethasone regulate insulin receptors, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in Fao hepatoma cells
29. Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo
30. Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction
31. Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor γ agonists
32. Adipose expression of tumor necrosis factor alpha: Direct role in obesity-linked insulin resistance
33. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance
34. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha
35. Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction
36. Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: Implication of the p80 tumor necrosis factor receptor
37. Tumor necrosis factor alpha: A key component of the obesity-diabetes link
38. The role of TNFalpha and TNF receptors in obesity and insulin resistance
39. TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone
40. Isoproterenol inhibits resistin gene expression through a G(S)-protein-coupled pathway in 3T3-L1 adipocytes
41. Hypertension and associated metabolic abnormalities: The role of insulin resistance and the sympathoadrenal system
42. Beta3-adrenergic stimulation differentially inhibits insulin signaling and decreases insulin-induced glucose uptake in brown adipocytes
43. Essential role of insulin receptor substrate-2 in insulin stimulation of Glut4 translocation and glucose uptake in brown adipocytes
44. Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment
45. Effects of human growth hormone on insulin-stimulated glucose metabolism in 3T3-F442A Adipocytes
46. Effects of growth hormone on insulin action in man: Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization
47. Effect of chronic growth hormone treatment on insulin signal transduction in rat tissues